TRIP13 and Miyoshi myopathy: Moreover, our previous studies have shown that knockdown Trip13 could against the growth of MM both in vivo and in vitro,23 suggesting Trip13 may represent an anti‐MM target and inhibition of Trip13 could be a promising therapeutic strategy for MM.